Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2000 1
2003 1
2006 1
2008 2
2009 1
2012 2
2013 1
2014 4
2016 1
2017 1
2018 2
2019 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
Shustov A, Soma L. Shustov A, et al. Cancer Treat Res. 2019;176:127-144. doi: 10.1007/978-3-319-99716-2_6. Cancer Treat Res. 2019. PMID: 30596216 Review.
Anaplastic Large Cell Lymphomas (ALCL) are clinically aggressive and pathologically distinct lymphoid neoplasms that originate from a mature post-thymic T-cell. The contemporary World Health Organization (WHO) Classification of Haematologic Malignancies recognizes t …
Anaplastic Large Cell Lymphomas (ALCL) are clinically aggressive and pathologically distinct lymphoid neoplasms that originate from a mature …
Treatment of cutaneous lymphomas: an update.
Izu-Belloso RM, García-Ruiz JC. Izu-Belloso RM, et al. Actas Dermosifiliogr. 2012 Oct;103(8):694-707. doi: 10.1016/j.ad.2012.01.011. Epub 2012 May 8. Actas Dermosifiliogr. 2012. PMID: 22575363 Free article. Review. English, Spanish.
Primary cutaneous lymphomas (PCLs) are a heterogeneous group of lymphoid tumors that originate primarily in the skin. Most PCLs (75%) are T-cell lymphomas and only 20% to 25% involve B cells. It is important to differentiate between cutaneous ly …
Primary cutaneous lymphomas (PCLs) are a heterogeneous group of lymphoid tumors that originate primarily in the skin. Most PCL …
Primary cutaneous T-cell lymphoma: review and current concepts.
Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM. Siegel RS, et al. J Clin Oncol. 2000 Aug;18(15):2908-25. doi: 10.1200/JCO.2000.18.15.2908. J Clin Oncol. 2000. PMID: 10920140 Review.
PURPOSE: Primary cutaneous T-cell lymphomas (CTCLs) encompass a wide variety of lymphomas that are characterized by the localization of the malignant lymphocytes to the skin at presentation. ...Treatment for MF/SS continues to be palliative. There are …
PURPOSE: Primary cutaneous T-cell lymphomas (CTCLs) encompass a wide variety of lymphomas that are characterized …
Update on the Treatment of Anaplastic Large Cell Lymphoma.
Vu K, Ai W. Vu K, et al. Curr Hematol Malig Rep. 2018 Apr;13(2):135-141. doi: 10.1007/s11899-018-0436-z. Curr Hematol Malig Rep. 2018. PMID: 29516333 Review.
PURPOSE OF REVIEW: Given the rarity of anaplastic large cell lymphoma (ALCL), studies evaluating new therapies have typically grouped ALCL together with other peripheral T cell lymphomas (PTCL). Thus, the treatment paradigm for ALCL largely mirrors tha …
PURPOSE OF REVIEW: Given the rarity of anaplastic large cell lymphoma (ALCL), studies evaluating new therapies have typically …
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas.
Zinzani PL, Bonthapally V, Huebner D, Lutes R, Chi A, Pileri S. Zinzani PL, et al. Crit Rev Oncol Hematol. 2016 Mar;99:228-40. doi: 10.1016/j.critrevonc.2015.12.018. Epub 2016 Jan 2. Crit Rev Oncol Hematol. 2016. PMID: 26811014 Free article. Review.
Primary cutaneous T-cell lymphomas (CTCLs), such as mycosis fungoides and Sezary syndrome, are a rare group of non-Hodgkin lymphomas, usually treated using a multimodal approach. Unfortunately, many patients go on to develop relapsed/refractory …
Primary cutaneous T-cell lymphomas (CTCLs), such as mycosis fungoides and Sezary syndrome, are a rare group of n …
Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management.
Scarisbrick JJ. Scarisbrick JJ. Future Oncol. 2017 Nov;13(27):2405-2411. doi: 10.2217/fon-2017-0263. Epub 2017 Aug 14. Future Oncol. 2017. PMID: 28805086 Review.
CD30-positive primary cutaneous T-cell lymphoma (CTCL) includes mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis type A. ...CD30 binding allows internalization of BV inducing cell-cycle arrest and apoptosis. Re …
CD30-positive primary cutaneous T-cell lymphoma (CTCL) includes mycosis fungoides, anaplastic large-cell …
Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update.
Ramelyte E, Dummer R, Guenova E. Ramelyte E, et al. Expert Opin Investig Drugs. 2019 Sep;28(9):799-809. doi: 10.1080/13543784.2019.1654995. Epub 2019 Aug 18. Expert Opin Investig Drugs. 2019. PMID: 31398295 Review.
Introduction: Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of skin-homing T-cell neoplasms, which represent approximately 75% of all primary cutaneous lymphomas. ...Larger trials are needed to better evaluate th …
Introduction: Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of skin-homing T-cell neop …
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions.
Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Jawed SI, et al. J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033. J Am Acad Dermatol. 2014. PMID: 24438970 Review.
In general, for limited patch and plaque disease, patients have excellent prognosis on 1 topical formulations, including topical corticosteroids and nitrogen mustard, with widespread patch/plaque disease often requiring phototherapy. In refractory early stage MF, transform …
In general, for limited patch and plaque disease, patients have excellent prognosis on 1 topical formulations, including topical corticoster …
Bexarotene in the treatment of cutaneous T-cell lymphoma.
Querfeld C, Nagelli LV, Rosen ST, Kuzel TM, Guitart J. Querfeld C, et al. Expert Opin Pharmacother. 2006 May;7(7):907-15. doi: 10.1517/14656566.7.7.907. Expert Opin Pharmacother. 2006. PMID: 16634713 Review.
Bexarotene was found to induce apoptosis in a variety of preclinical in vitro and in vivo models including cutaneous T-cell lymphoma cells, and has shown efficacy in two multi-centre, open-label Phase II - III clinical trials for early and advanced sta …
Bexarotene was found to induce apoptosis in a variety of preclinical in vitro and in vivo models including cutaneous T-cell …
Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.
Renna S, Cottone M, Orlando A. Renna S, et al. World J Gastroenterol. 2014 Aug 7;20(29):9675-90. doi: 10.3748/wjg.v20.i29.9675. World J Gastroenterol. 2014. PMID: 25110407 Free PMC article. Review.
An adequate dosage and duration of therapy with thiopurines should be reached before evaluating their efficacy. ...The use of thalidomide and mycophenolate mofetil is not recommended in patients with inflammatory bowel disease, these treatments could be considered in case …
An adequate dosage and duration of therapy with thiopurines should be reached before evaluating their efficacy. ...The use of thalido …
20 results